Skip to main content
SpringerLink
Log in

Antineoplastics

Development of resistance: 12 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chen C, et al. Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib. Nan Fang Yi Ke Da Xue Xue Bao 39: 364-368, No. 3, 30 Mar 2019. Available from: URL: http://doi.org/10.12122/j.issn.1673-4254.2019.03.16 [Chinese; summarised from a translation] - China

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antineoplastics. Reactions Weekly 1772, 46 (2019). https://doi.org/10.1007/s40278-019-68173-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-68173-9

Search

Navigation